| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA | Director | Common Stock | 6,536 | $2,739,042 | $419.07 | 10 Aug 2023 | Direct |
| VERTEX PHARMACEUTICALS INC / MA | Director | Stock Option (Right to Buy) | 3,142 | $256,199 | $81.54 | 01 May 2024 | Direct |
| ACCELERON PHARMA INC | Director | Common Stock | 0 | $29.37 | 19 Nov 2021 | Direct | |
| ACCELERON PHARMA INC | Director | Option to Purchase Common Stock | 0 | 19 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VRTX | VERTEX PHARMACEUTICALS INC / MA | 01 May 2024 | 1 | $0 | 4 | Director | 03 May 2024, 16:14 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | 10 Aug 2023 | 3 | -$2,224,600 | 4 | Director | 14 Aug 2023, 16:09 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | 01 May 2023 | 1 | $0 | 4 | Director | 03 May 2023, 16:55 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | 01 May 2022 | 2 | $0 | 4 | Director | 03 May 2022, 17:41 |
| XLRN | ACCELERON PHARMA INC | 19 Nov 2021 | 6 | $0 | 4 | Director | 22 Nov 2021, 08:08 |